Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Chemotherapy With Pemetrexed and Cisplatin vs. Vinorelbine and Cisplatin in NSCLC IB, IIA, IIB, T3N1: a Randomized Phase II Study

NCT00349089 is registered in ClinicalTrials.gov with Thoraxklinik-Heidelberg gGmbH as lead sponsor.

NCT NCT00349089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00349089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Chemotherapy With Pemetrexed and Cisplatin vs. Vinorelbine and Cisplatin in NSCLC IB, IIA, IIB, T3N1: a Randomized Phase II Study
Lead sponsor
Thoraxklinik-Heidelberg gGmbH
Phase
Phase 2
Overall status
Completed
Start date
September 26, 2006
Completion date
April 14, 2014
Enrollment
132 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer